Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIRZEPATIDE Cause Injury associated with device? 836 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 836 reports of Injury associated with device have been filed in association with TIRZEPATIDE (Zepbound). This represents 0.8% of all adverse event reports for TIRZEPATIDE.

836
Reports of Injury associated with device with TIRZEPATIDE
0.8%
of all TIRZEPATIDE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Injury associated with device From TIRZEPATIDE?

Of the 836 reports, 2 (0.2%) required hospitalization.

Is Injury associated with device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 836 reports have been filed with the FAERS database.

What Other Side Effects Does TIRZEPATIDE Cause?

Incorrect dose administered (23,301) Injection site pain (10,989) Nausea (10,018) Off label use (7,007) Extra dose administered (6,774) Diarrhoea (5,463) Vomiting (4,635) Injection site haemorrhage (4,389) Accidental underdose (3,897) Injection site erythema (3,844)

What Other Drugs Cause Injury associated with device?

COPPER (2,895) ADALIMUMAB (2,003) EVOLOCUMAB (1,326) INSULIN GLARGINE (849) INSULIN LISPRO (840) ETANERCEPT (743) ERENUMAB-AOOE (528) DULAGLUTIDE (482) ENOXAPARIN (458) INTERFERON BETA-1A (421)

Which TIRZEPATIDE Alternatives Have Lower Injury associated with device Risk?

TIRZEPATIDE vs TISAGENLECLEUCEL TIRZEPATIDE vs TISLELIZUMAB TIRZEPATIDE vs TISOTUMAB VEDOTIN TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC

Related Pages

TIRZEPATIDE Full Profile All Injury associated with device Reports All Drugs Causing Injury associated with device TIRZEPATIDE Demographics